ResearcherKawasaki Municipal HospitalActive in the last 2 years
Sojun Hoshimoto
Matched on OpenAlex author ID A5112547025. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 8
- Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Tria… Co-author DOI 10.1245/s10434-025-17661-7↗
- Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pan… Co-author DOI 10.1016/j.pan.2019.12.004↗
- Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study. Co-author DOI 10.1007/s00423-019-01841-7↗
- Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13455↗
- Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.ejso.2017.03.020↗
- Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.11.001↗
- Mass-forming type 1 autoimmune pancreatitis mimicking pancreatic cancer. Co-author DOI 10.1111/1751-2980.12316↗
- Successful resolution of a hemorrhagic pancreatic pseudocyst ruptured into the stomach complicating obstructive pancreatitis due to pancreatic cancer: a case r… Co-author DOI 10.1186/s12957-016-0812-x↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshiro Ogata · 5 shared papers, 2017–2020 · strength 0.49
- Paper Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in … DOI 10.1016/j.pan.2019.12.004↗
- Paper Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study. DOI 10.1007/s00423-019-01841-7↗
- Paper Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Can… DOI 10.21873/anticanres.13455↗
- Koichi Aiura · 3 shared papers, 2016–2025 · strength 0.36
- Paper Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Can… DOI 10.1245/s10434-025-17661-7↗
- Paper Successful resolution of a hemorrhagic pancreatic pseudocyst ruptured into the stomach complicating obstructive pancrea… DOI 10.1186/s12957-016-0812-x↗
- Paper Mass-forming type 1 autoimmune pancreatitis mimicking pancreatic cancer. DOI 10.1111/1751-2980.12316↗
- Yutaka Endo · 1 shared paper, 2025 · strength 0.22
- Minoru Kitago · 1 shared paper, 2025 · strength 0.22
- Yutaka Takigawa · 1 shared paper, 2025 · strength 0.22
- Yuta Abe · 1 shared paper, 2025 · strength 0.22
- Yutaka Nakano · 1 shared paper, 2025 · strength 0.22
- Yosuke Uematsu · 1 shared paper, 2025 · strength 0.22
- Junichi Matsui · 1 shared paper, 2025 · strength 0.22
- Yuko Kitagawa · 1 shared paper, 2025 · strength 0.22
- Hitoshi Sugiura · 2 shared papers, 2016 · strength 0.15
- Chisato Takagi · 1 shared paper, 2019 · strength 0.10
- Motomu Tanaka · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.